This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Oncology  • Lung Cancer  • Tobacco  • Pulmonary Diseases, Other  • Alert me on articles by topic

Lawrence J. Dacey, MD, MS; David W. Johnstone, MD

JAMA. 2005;294:1550-1551.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The costs of tobacco in both health and economic terms are enormous. Cigarette smoking causes approximately 5 million premature deaths each year around the world secondary to cardiovascular disease, chronic obstructive pulmonary disease, and lung cancer.¹ In the United States, lung cancer is the leading cause of cancer-related deaths for both men and women. More than 170 000 new cases of lung cancer (13% of all cancer diagnoses) will be diagnosed this year, and more than 160 000 deaths from lung cancer will occur (28% of all cancer deaths).² The 5-year survival for all patients who receive a diagnosis of lung cancer is an abysmal 14%, and even those who are diagnosed and definitively treated at the earliest stage (IA) have only a 67% 5-year survival.³ In the United States, direct medical costs for the treatment of lung cancer alone are approximately $5 . . . [Full Text of this Article]

Author Affiliations: Departments of Surgery and Community and Family Medicine (Dr Dacey) and Department of Surgery (Dr Johnstone), Dartmouth-Hitchcock Medical Center, Lebanon, NH.

RELATED ARTICLES

Dietary Phytoestrogens and Lung Cancer Risk
Matthew B. Schabath, Ladia M. Hernandez, Xifeng Wu, Patricia C. Pillow, and Margaret R. Spitz
JAMA. 2005;294(12):1493-1504.
ABSTRACT | FULL TEXT  

Effect of Smoking Reduction on Lung Cancer Risk
Nina S. Godtfredsen, Eva Prescott, and Merete Osler
JAMA. 2005;294(12):1505-1510.
ABSTRACT | FULL TEXT